Sign in
8-K

Current Report

Spero Therapeutics, Inc. Filed Acc 0001193125-24-246627

Results of operations · Exit or restructuring costs · Regulation FD disclosure · Other events

  • Item 2.02 Results of operations and financial condition
  • Item 2.05 Costs associated with exit or disposal activities
  • Item 7.01 Regulation FD disclosure
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading d889032d8k.htm…